COPHF:Creso Pharma Ltd - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
52-Week Low/High Stock Price$0.15 - $1.00
Percent Held by Institutions0.00%
PE Ratio to Industry43%
Debt-Equity to Industry1.06%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateSep. 16, 2019
No Data available for Payment History.
Creso Pharma is an Australia-based company engaged in developing cannabis and hemp-derived therapeutic-grade Nutraceuticals and Medical Cannabis products with a range of applications in both human and animal health. Co.'s principal activity is to develop, register and commercialize pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments. Co.'s segments include Hemp-Industries s.r.o. (Hemp-Industries), which includes hemp-growing operations, outsourced cannabidiol (CBD) extraction and CBD product sales activities; Creso Pharma Switzerland GmbH (Switzerland), which includes the development and commercialization of its therapeutic products, and Creso Pharma Limited (Creso), which includes Co.'s corporate administration. Co. primarily offers human health and animal health products, and hemp-derived extracts, oils and proteins.
SegmentPharmaceuticals & Biotechnology
Dividend AllStar™ Ranking
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Sep. 13, 2019CLOSE PRICE DECREASE: Creso Pharma Ltd (OTCBB: COPHF) on 09-13-2019 decreased close price > 10% from $0.52 to $0.25Read more...
Sep. 12, 2019CLOSE PRICE INCREASE: Creso Pharma Ltd (OTCBB: COPHF) on 09-12-2019 increased close price > 10% from $0.30 to $0.52Read more...
Aug. 29, 2019CLOSE PRICE DECREASE: Creso Pharma Ltd (OTCBB: COPHF) on 08-29-2019 decreased close price > 10% from $0.32 to $0.26Read more...
Sep. 20, 2019CLOSE PRICE DECREASE: IGM Biosciences Inc (NASDAQ: IGMS) on 09-20-2019 decreased close price > 10% from $24.30 to $20.66Read more...
Sep. 20, 2019CLOSE PRICE DECREASE: OncBioMune Pharmaceuticals Inc (OTCBB: OBMPD) on 09-20-2019 decreased close price > 10% from $1.20 to $1.00Read more...
Sep. 20, 2019CLOSE PRICE DECREASE: Core One Labs Inc (OTCBB: LDSYD) on 09-20-2019 decreased close price > 10% from $0.72 to $0.62Read more...